• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢综合征的血脂异常干预:重点在于改善血脂和减少临床事件。

Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction.

机构信息

Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, the University of Queensland School of Medicine, New Orleans, Louisiana 70121, USA.

出版信息

Am J Med Sci. 2011 May;341(5):388-93. doi: 10.1097/MAJ.0b013e31821483fa.

DOI:10.1097/MAJ.0b013e31821483fa
PMID:21519201
Abstract

The metabolic syndrome is a common disorder characterized by central (especially intra-abdominal) obesity, hypertension, impaired glucose tolerance and atherogenic dyslipidemia (including the combination of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol). In this article, the authors review interventions to improve this lipid profile and potentially reduce the risk of major cardiovascular events in patients with metabolic syndrome.

摘要

代谢综合征是一种常见的疾病,其特征为中心性(尤其是腹部)肥胖、高血压、葡萄糖耐量受损和致动脉粥样硬化性血脂异常(包括高三酰甘油血症和低水平高密度脂蛋白胆固醇血症的组合)。本文作者综述了改善血脂谱并可能降低代谢综合征患者发生主要心血管事件风险的干预措施。

相似文献

1
Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction.代谢综合征的血脂异常干预:重点在于改善血脂和减少临床事件。
Am J Med Sci. 2011 May;341(5):388-93. doi: 10.1097/MAJ.0b013e31821483fa.
2
Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.代谢综合征血脂异常的管理:超越他汀类药物治疗。
Metab Syndr Relat Disord. 2012 Jun;10(3):159-60. doi: 10.1089/met.2012.1500. Epub 2012 May 8.
3
Obesity and lipids.肥胖与脂质。
Curr Cardiol Rep. 2005 Nov;7(6):465-70. doi: 10.1007/s11886-005-0065-8.
4
[Lipid-lowering treatment in metabolic syndrome].
Vnitr Lek. 2009 Jul-Aug;55(7-8):626-30.
5
Combination lipid therapy in type 2 diabetes mellitus.2 型糖尿病的联合脂质治疗。
Expert Opin Pharmacother. 2011 Jun;12(9):1393-403. doi: 10.1517/14656566.2011.558503. Epub 2011 Feb 16.
6
[Residual risk of cardiovascular complications and its reduction with a combination of lipid lowering agents].[心血管并发症的残余风险及其通过联合降脂药物降低的情况]
Vnitr Lek. 2011 Mar;57(3):313-6.
7
[Efficacy studies].[疗效研究]
Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:17-9. doi: 10.1016/S0214-9168(14)70021-X.
8
Pathogenesis and management of the dyslipidemia of the metabolic syndrome.代谢综合征血脂异常的发病机制与管理
Metab Syndr Relat Disord. 2009 Apr;7(2):83-8. doi: 10.1089/met.2008.0079.
9
[Indications for the combination of pravastatin and fenofibrate according to the type of dyslipidemia].[根据血脂异常类型使用普伐他汀与非诺贝特联合治疗的指征]
Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:31-4. doi: 10.1016/S0214-9168(14)70024-5.
10
Atherogenic dyslipidemia.致动脉粥样硬化性血脂异常
J Cardiometab Syndr. 2006 Summer;1(3):166-7.

引用本文的文献

1
Obesity Subtyping: The Etiology, Prevention, and Management of Acquired versus Inherited Obese Phenotypes.肥胖亚型:获得性与遗传性肥胖表型的病因、预防和管理。
Nutrients. 2022 May 30;14(11):2286. doi: 10.3390/nu14112286.
2
The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review.贝特类药物对糖尿病和代谢综合征微血管及大血管的益处:综述
Mo Med. 2017 Nov-Dec;114(6):464-471.
3
Management of cardiovascular diseases in patients with obesity.肥胖患者的心血管疾病管理。
Nat Rev Cardiol. 2018 Jan;15(1):45-56. doi: 10.1038/nrcardio.2017.108. Epub 2017 Jul 27.
4
Effects of Lactobacillus plantarum TWK10-Fermented Soymilk on Deoxycorticosterone Acetate-Salt-Induced Hypertension and Associated Dementia in Rats.植物乳杆菌TWK10发酵豆浆对醋酸脱氧皮质酮-盐诱导的大鼠高血压及相关痴呆的影响
Nutrients. 2016 May 2;8(5):260. doi: 10.3390/nu8050260.
5
Managing metabolic syndrome in women.女性代谢综合征的管理
Nurse Pract. 2012 Aug 10;37(8):14-20; quiz 20-1. doi: 10.1097/01.NPR.0000415871.60058.69.
6
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase.免疫调节酶吲哚胺 2,3-双加氧酶缺乏引起的心脏和胃肠道不良事件。
Cancer Biol Ther. 2011 Dec 15;12(12):1050-8. doi: 10.4161/cbt.12.12.18142.